Hologic - Breast Ultrasound, MRI and Tomosynthesis are Highlights

Tools to spot, diagnose and treat cancer in women were among the products highlighted by Hologic Inc. during the 2010 RSNA show in Chicago.

The Selenia Dimensions 3-D breast tomosynthesis system addresses the primary limitations of 2-D digital mammography – the superimposition of normal breast tissue. Launched in Europe in September 2008, the system delivers both conventional digital mammogram and a tomosynthesis exam - all under one compression. The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has issued an “approvable letter” for the Selenia Dimensions system for breast tomosynthesis (3-D) imaging.

With the acquisition of Sentinelle Medical Inc., Hologic added a suite of breast magnetic resonance imaging (MRI) tools to its portfolio. Products include the Sentinelle breast MRI coil and the Sentinelle Aegis breast imaging and interventional software.

Hologic also offers alternatives to open surgical breast biopsy. The company offers the ATEC, Eviva and Celero breast biopsy devices, the Eviva upright biopsy system and ergonomically engineered MultiCare Platinum breast biopsy table. New at RSNA was a works-in-progress Abrivo breast biopsy device and Affirm breast biopsy guidance system. The Affirm stereotactic-guided biopsy device is specifically designed for the Selenia Dimensions system.

Another highlight was a display of the Aixplorer Multiwave ultrasound system. Under the terms of a new agreement, Hologic will sell, install and service SuperSonic Imagine’s Aixplorer ultrasound technology platform to the breast care community in the United States.

For more information: www.hologic.com


Related Content

News | Magnetic Resonance Imaging (MRI)

Feb. 6, 2026 — A state-of-the-art intraoperative MRI (iMRI) has arrived at the University of Chicago Medicine, one of ...

Time February 06, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Computed Tomography (CT)

Feb. 4, 2026 — A new review published in the American Journal of Roentgenology (AJR) finds that advances in CT ...

Time February 04, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
Subscribe Now